A study to evaluate the preventive effect of Matcha tea on decline in cognitive function and decline in daily living activity

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2019
INTERVENTION: Ingest of powdered Matcha capsules, 9 capsules a day, for 12 months. Ingest of placebo capsules, 9 capsules a day, for 12 months. CONDITION: Mild cognitive impairment (MCI) Pre‐MCI PRIMARY OUTCOME: Neuropsychological test (MoCA‐J) and activities of daily living scale (ADCS‐MCI‐ADL) before ingestion, and after ingestion of Matcha tea or placebo for 6 months and for 12 months. SECONDARY OUTCOME: Neuropsychological test (MMSE‐J, RBANS, ADAS‐Jcog, Cognitrax); The Pittsburgh Sleep Quality Index INCLUSION CRITERIA:
Epistemonikos ID: ed7fd39a81fd33363b8c1dca19e935127d6a0eb1
First added on: Aug 24, 2024